1. Home
  2. KVHI vs INO Comparison

KVHI vs INO Comparison

Compare KVHI & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

N/A

Current Price

$7.59

Market Cap

136.4M

Sector

Technology

ML Signal

N/A

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

N/A

Current Price

$1.29

Market Cap

133.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVHI
INO
Founded
1978
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.4M
133.4M
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
KVHI
INO
Price
$7.59
$1.29
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
162.1K
4.7M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
54.18
EPS
0.04
N/A
Revenue
$9,622,000.00
$42,220,086.00
Revenue This Year
$28.90
$20,156.19
Revenue Next Year
$31.85
$421.95
P/E Ratio
$188.00
N/A
Revenue Growth
3.82
19.37
52 Week Low
$5.09
$0.56
52 Week High
$13.00
$2.86

Technical Indicators

Market Signals
Indicator
KVHI
INO
Relative Strength Index (RSI) 39.40 64.40
Support Level $7.32 $1.03
Resistance Level $7.67 $1.79
Average True Range (ATR) 0.32 0.11
MACD -0.00 0.03
Stochastic Oscillator 35.68 86.36

Price Performance

Historical Comparison
KVHI
INO

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: